Market Overview:
The global topical drug delivery system market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic diseases, rising geriatric population, and technological advancements in topical drug delivery systems. The skin drug delivery segment is expected to dominate the global topical drug delivery system market during the forecast period. This can be attributed to the increasing demand for minimally invasive procedures and growing awareness about advanced technologies among consumers. The ophthalmic drug delivery segment is projected to grow at a high CAGR during the forecast period owing to rising incidence of eye disorders and technological advancements in this field. In terms of application, hospitals and private clinics are expected to dominate the global topical drug delivery system market during the forecast period as these institutions offer better reimbursement rates for advanced therapies such as those delivered through topical drugs Delivery Systems (TDS).
Product Definition:
A topical drug delivery system is a medication that is applied to the skin. This type of medication is often used to treat skin conditions, such as eczema, psoriasis, and acne. The topical drug delivery system can also be used to deliver medications through the eyes or nose.
Skin Drug Delivery:
Skin drug delivery is a system that uses the skin as a route of drug administration. It's major advantages are safety, easy application and availability of the target organ (skin) which results in higher bioavailability.
The global market size was valued at USD 4,48 billion in 2016 and is expected to grow at a CAGR of XX% over the forecast period.
Ophthalmic Drug Delivery:
Ophthalmic drug delivery is the process of transporting drugs to the site of action in the eye. The ophthalmic drug delivery system market is expected to witness lucrative growth over forecast period owing to increasing prevalence of chronic diseases such as glaucoma, cataract, and others. Moreover, growing demand for non-invasive surgical procedures coupled with increasing geriatric population base across globe will serve this market as a high impact rendering driver.
Application Insights:
Based on application, the market is segmented into hospitals and private clinics, home care settings, and others. The hospitals and private clinics segment dominated the market in 2017 owing to factors such as increasing geriatric population that requires medical attention along with rising number of hospital-acquired diseases. For instance, according to a study published by NCBI in 2018, it was found that hospital acquired infections were more than 200% higher than those contracted outside of a hospital setting. Thus topical drug delivery system manufacturers are focusing on developing products for use at home care settings or other non-clinical areas such as ophthalmic drug delivery systems or rectal drug delivery systems where infection control is crucial for patient safety.
The others application segment includes dentistry and veterinary applications where Topical Drug Delivery Systems (TDD) are used for pain management along with providing anesthesia during procedures like tooth extraction or dental x-rays among other uses within these industries.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large number of key players and well-established healthcare infrastructure. Moreover, increasing R&D investments by companies and government for topical drug delivery systems is also expected to drive growth over the forecast period. Asia Pacific is anticipated to witness lucrative growth during the forecast period due to rising disposable income levels, improving healthcare facilities & infrastructure, growing awareness about various treatment options available for chronic diseases such as diabetes and acne vulgaris, increase in spending capacity among patients as well as their families are some factors that can be attributed towards this rapid development of market. In addition, favorable government initiatives pertaining with reimbursement policies are further expected to boost demand across this region.
Moreover, economic reforms in China have resulted in an increased availability & accessibility of medicines which has further led towards high demand across this region during 2016’17 timeframe (Global Topical Drug Delivery System Market Report By Application).
Growth Factors:
- Increasing prevalence of skin diseases and disorders: The global prevalence of skin diseases is increasing every year. This is mainly due to the changing lifestyles and environmental conditions. According to a study by the World Health Organization (WHO), it is estimated that nearly 3 billion people suffer from various skin problems such as acne, psoriasis, eczema, and rosacea. This number is expected to increase in the coming years owing to the increasing population and changing lifestyle patterns. Thus, there will be an increased demand for topical drug delivery systems that can provide better treatment outcomes for these patients.
- Growing awareness about advanced topical drug delivery systems: There has been a growing awareness among patients about the benefits of using advanced topical drug delivery systems over traditional methods such as oral or injectable drugs. These systems offer many advantages such as improved patient compliance, reduced side effects, enhanced efficacy, etc., which have led to their increased adoption in recent years.
- Technological advancements in topical drug delivery system: The technological advancements in this field are helping to improve the performance of these devices significantly while reducing their costs at the same time. For instance, newer technologies are being developed that can help deliver drugs deep into tissues through minimally invasive procedures thereby reducing potential side effects associated with them.. This is likely to boost market growth over the forecast period..
Scope Of The Report
Report Attributes
Report Details
Report Title
Topical Drug Delivery System Market Research Report
By Type
Skin Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery, Vaginal Drug Delivery, Nasal Drug Delivery
By Application
Hospitals and Private Clinics, Home Care Settings, Others
By Companies
Glaxosmithkline, Johnson & Johnson, Novartis, Galderma S.A., Valeant Pharmaceuticals International, Inc., Bayer AG, 3M Drug Delivery Systems, Crescita Therapeutics Inc., Medpharm, Cipla
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
175
Number of Tables & Figures
123
Customization Available
Yes, the report can be customized as per your need.
Global Topical Drug Delivery System Market Report Segments:
The global Topical Drug Delivery System market is segmented on the basis of:
Types
Skin Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery, Vaginal Drug Delivery, Nasal Drug Delivery
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals and Private Clinics, Home Care Settings, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Glaxosmithkline
- Johnson & Johnson
- Novartis
- Galderma S.A.
- Valeant Pharmaceuticals International, Inc.
- Bayer AG
- 3M Drug Delivery Systems
- Crescita Therapeutics Inc.
- Medpharm
- Cipla
Highlights of The Topical Drug Delivery System Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Skin Drug Delivery
- Ophthalmic Drug Delivery
- Rectal Drug Delivery
- Vaginal Drug Delivery
- Nasal Drug Delivery
- By Application:
- Hospitals and Private Clinics
- Home Care Settings
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Topical Drug Delivery System Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A topical drug delivery system is a device that helps deliver medications to the skin. Topical drug delivery systems can be in the form of creams, lotions, gels, patches, or sprays.
Some of the key players operating in the topical drug delivery system market are Glaxosmithkline, Johnson & Johnson, Novartis, Galderma S.A., Valeant Pharmaceuticals International, Inc., Bayer AG, 3M Drug Delivery Systems, Crescita Therapeutics Inc., Medpharm, Cipla.
The topical drug delivery system market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Topical Drug Delivery System Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Topical Drug Delivery System Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Topical Drug Delivery System Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Topical Drug Delivery System Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Topical Drug Delivery System Market Size & Forecast, 2018-2028
4.5.1 Topical Drug Delivery System Market Size and Y-o-Y Growth
4.5.2 Topical Drug Delivery System Market Absolute $ Opportunity
Chapter 5 Global Topical Drug Delivery System Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Topical Drug Delivery System Market Size Forecast by Type
5.2.1 Skin Drug Delivery
5.2.2 Ophthalmic Drug Delivery
5.2.3 Rectal Drug Delivery
5.2.4 Vaginal Drug Delivery
5.2.5 Nasal Drug Delivery
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Topical Drug Delivery System Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Topical Drug Delivery System Market Size Forecast by Applications
6.2.1 Hospitals and Private Clinics
6.2.2 Home Care Settings
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Topical Drug Delivery System Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Topical Drug Delivery System Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Topical Drug Delivery System Analysis and Forecast
9.1 Introduction
9.2 North America Topical Drug Delivery System Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Topical Drug Delivery System Market Size Forecast by Type
9.6.1 Skin Drug Delivery
9.6.2 Ophthalmic Drug Delivery
9.6.3 Rectal Drug Delivery
9.6.4 Vaginal Drug Delivery
9.6.5 Nasal Drug Delivery
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Topical Drug Delivery System Market Size Forecast by Applications
9.10.1 Hospitals and Private Clinics
9.10.2 Home Care Settings
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Topical Drug Delivery System Analysis and Forecast
10.1 Introduction
10.2 Europe Topical Drug Delivery System Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Topical Drug Delivery System Market Size Forecast by Type
10.6.1 Skin Drug Delivery
10.6.2 Ophthalmic Drug Delivery
10.6.3 Rectal Drug Delivery
10.6.4 Vaginal Drug Delivery
10.6.5 Nasal Drug Delivery
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Topical Drug Delivery System Market Size Forecast by Applications
10.10.1 Hospitals and Private Clinics
10.10.2 Home Care Settings
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Topical Drug Delivery System Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Topical Drug Delivery System Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Topical Drug Delivery System Market Size Forecast by Type
11.6.1 Skin Drug Delivery
11.6.2 Ophthalmic Drug Delivery
11.6.3 Rectal Drug Delivery
11.6.4 Vaginal Drug Delivery
11.6.5 Nasal Drug Delivery
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Topical Drug Delivery System Market Size Forecast by Applications
11.10.1 Hospitals and Private Clinics
11.10.2 Home Care Settings
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Topical Drug Delivery System Analysis and Forecast
12.1 Introduction
12.2 Latin America Topical Drug Delivery System Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Topical Drug Delivery System Market Size Forecast by Type
12.6.1 Skin Drug Delivery
12.6.2 Ophthalmic Drug Delivery
12.6.3 Rectal Drug Delivery
12.6.4 Vaginal Drug Delivery
12.6.5 Nasal Drug Delivery
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Topical Drug Delivery System Market Size Forecast by Applications
12.10.1 Hospitals and Private Clinics
12.10.2 Home Care Settings
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Topical Drug Delivery System Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Topical Drug Delivery System Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Topical Drug Delivery System Market Size Forecast by Type
13.6.1 Skin Drug Delivery
13.6.2 Ophthalmic Drug Delivery
13.6.3 Rectal Drug Delivery
13.6.4 Vaginal Drug Delivery
13.6.5 Nasal Drug Delivery
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Topical Drug Delivery System Market Size Forecast by Applications
13.10.1 Hospitals and Private Clinics
13.10.2 Home Care Settings
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Topical Drug Delivery System Market: Competitive Dashboard
14.2 Global Topical Drug Delivery System Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Glaxosmithkline
14.3.2 Johnson & Johnson
14.3.3 Novartis
14.3.4 Galderma S.A.
14.3.5 Valeant Pharmaceuticals International, Inc.
14.3.6 Bayer AG
14.3.7 3M Drug Delivery Systems
14.3.8 Crescita Therapeutics Inc.
14.3.9 Medpharm
14.3.10 Cipla
